Description
Indications of active substances of the drug Letrozol Zentiva Filmtabletten 2.5mg 100 Stück
Early stages of invasive breast cancer whose cells have hormone receptors, in postmenopausal women, as adjuvant therapy. Early-stage invasive breast cancer in postmenopausal women after completion of standard adjuvant therapy with tamoxifen for 5 years as extended adjuvant therapy. Disseminated hormone-dependent breast cancer in postmenopausal women (first-line therapy). Disseminated breast cancer with recurrence or disease progression in postmenopausal women (natural or artificially induced) who have received prior anti-estrogen therapy. HER-2 negative hormone-dependent breast cancer in postmenopausal women as neoadjuvant therapy in case of contraindications to chemotherapy and no need for emergency surgery.
Side effects
- Hematopoietic system: infrequently – leucopenia.
- Immune system: frequency unknown – anaphylactic reactions.
- Metabolism: very often – hypercholesterolaemia; often – anorexia, increased appetite.
- Mental disorders: often – depression; infrequently – anxiety (including nervousness), irritability.
Reviews
There are no reviews yet.